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MacronutrientsAbstract Introduction: Different studies have shown the role of micro and macronutrients on cog-
nitive function.Macronutrients have been involved inmanymetabolic activities of the body including
oxidation and reduction reactions in the central nervous system. This involvement of macronutrients
in the activities of central nervous system indicates its role in cognition. The present study is designed
to know the role of macronutrients and its relation with cognition by using biological samples.
Materials and methods: A total of 337 subjects with a mean age of 49 participated in the cross sectional
study fromdifferentparts ofKerala state in India. Individualsparticipating in this studywereadministered
a series of neuropsychological test batteries with major emphasis on 7-min screen test. All test procedures
were administered by standard protocol after a written consent was obtained from the participating sub-
jects. Analysis of macronutrients level of magnesium, calcium and phosphorus was done by using serum
samples and the data obtained were then statistically analyzed using SPSS software version 17.
Results: Themacronutrients magnesium, calcium and phosphorus were found to be significantly related
to the cognitive score. Increasingmagnesium and calcium level was associated with higher cognitive score
(P< 0.0031 and 0.001 respectively), while lower phosphorus level was significantly associated with lower
composite score (P< 0.001).
Conclusion: The results of our study give us an expression that macronutrients such as calcium, magne-
sium and phosphorus may be associated with cognitive function in elderly population of our state. But
further studies on a larger population are required to come out with a definite conclusion.
 2015 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Nutrients involved in the etiology and pathogenesis of several
age-related central nervous system (CNS) abnormalities.1–3
Magnesium (Mg2+), the fourth most abundant ion in the body
and a cofactor for more than 300 enzymes, is essential to all
organisms.4 It is one of the most important ions in the central
nervous system and dietary deficiency of Mg2+ increases the
neurotoxicity.5 Mg2+ concentration is higher in the cere-
brospinal fluid than in plasma, which is maintained by an
active transport process. Magnesium serves several physiologic
and homeostatic functions, including the regulation of neuro-
muscular and vascular tone6 and the noncompetitive blockade
of the NMDA-receptor channel, thereby acting as a calcium
(Ca) antagonist.7–10 Magnesium is also essential for membrane
stability and fluidity, RNA aggregation and DNA and protein
synthesis. Because of its involvement in a number of bioener-
getic and biochemical activities, magnesium appears to play
an important role in normal neuronal activity.11 Mg2+ is a
positive regulator of synaptic plasticity; increasing Mg2+ con-
centration in the extracellular fluid within the physiological
range leads to permanent enhancement of synaptic plasticity
in networks of cultured hippocampal neurons in vitro.12 It
has been suggested that Alzheimer’s disease (AD) involves a
defective transport process characterized by both an abnor-
mally low Mg incorporation and abnormally high aluminum
(Al) incorporation in brain neurons.13 The origin of this distur-
bance rests on an alteration of serum albumin, forming a spe-
cies which has greater affinity for Al than for Mg, in contrast
to the normal protein which binds with Mg better than Al. The
altered albumin crosses the blood–brain barrier more effi-
ciently than the normal protein and competes with it in bind-
ing to brain neurons. Binding of altered albumin to the target
neurons would both impede Mg uptake and facilitate Al
uptake. Low level of Mg overexcites the brain’s neurons and
results in less coherence. It was hypothesized that the Mg
depletion by increasing Ca/Mg ratio in the CNS tissues further
accelerates the uptake of Al into the CNS, which promotes the
neurodegenerative processes.5,14 Another important element in
the serum is phosphorus (P), which is a vital constituent of
nucleic acids, organic phosphates, and adenosine triphosphate
(ATP). As magnesium, calcium and phosphorous are impor-
tant macronutrients for the CNS functioning, the present
study is designed to evaluate their levels in maintaining cogni-
tion in elderly population of South India.
2. Materials and methods
2.1. Participants
Participants were a part of the cross-sectional study of Calicut
University Project to Investigate Memory and Ageing (CUP-
TIMA), as adapted and standardized for Malayalam speaking
population.15 We administered a series of Neuropsychological
test batteries (7-min Screen Test, CERAD Memory function
test, Trail Making Test-TMT, Global versus Local attention
task test, Handedness test, Mini Mental State Examination-
MMSE and Geriatric Depression Scale-GDS) to 337 healthy
individuals belonging to various places of Kerala state in
India, especially Thrissur, Palakkad, Malappuram and Kozhi-
kode districts, for about a 7 year period. All of them exceptthree were right handed and none of them were inarticulate.
Only participants who were having no history of stroke, head
trauma, neurological disease, psychological illness, or any
other known present illness and those who know Malayalam
or English or both were chosen as participants. Individual par-
ticipants were subjected to different test batteries.
Participants ranged from ages of 20 to 84 years with a mean
age of 49 have educational backgrounds ranging from four to
twenty years. Participants were grouped into categories based
on their sex, age and education. All test procedures were
explained and a written consent was obtained from each of
them. All the tests were administered based on standard proto-
cols (Oxford Project To Investigate Memory and Ageing
[OPTIMA], Cambridge Mental Disorders of the Elderly
Examination (CAMDEX) and CUPTIMA).
2.2. Methods
The 7-min screen test was developed to test cognitive impair-
ment especially dementia prone Alzheimer’s disease. The vari-
ous tests coming under this are orientation test, memory test,
clock drawing test and verbal fluency test. The scores obtained
from all the above tests were then analyzed using the scoring
calculator, to find out the probability of dementia related
problems.16 Serum calcium, magnesium and phosphorus were
estimated with their respective slide by Johnson and Johnson
fully automatic analyzer (Vitros FS 5.1, Johnson and
Johnson).
2.3. Statistical analysis
The data of biochemical test parameters were analyzed with
SPSS software version 17. The following statistical tests were
conducted for analysis, which include ANOVA, Independent
sample test and Pearson correlation.
3. Results
The 7-min screen test was administered in all the age groups
and found an increasing trend in the score as age advanced
(Table 1). Orientation score in younger age group was com-
pared with older age groups. A statistically significant differ-
ence was found between younger age group (20–29) and
other groups (p< 0.05). One way ANOVA was conducted
between the groups and within the groups and a mean square
value of 52.847 and 0.518 respectively with a highly significant
p value (<0.001) was observed. The score in male was 1.4
± 1.14 and in female was 1.58 ± 1.266. No statistically signif-
icant difference was observed between the scores in male and
female (p= 0.171).
It was also found that when the education level increased
the orientation score decreased. A statistically significant dif-
ference was observed between the highly educated and the une-
ducated in the Orientation test score (p< 0.001). In primary
educated group, the value was 2.02 ± 1.10, in the secondary
educated group, the value was 1.23 ± 1.16 but in the tertiary
educated group, it was 0.98 ± 1.11. The values were statisti-
cally highly significant (p< 0.001).
Memory test was administered in all the age groups and
was found to have a decreasing trend in the score as age
advances. Memory test in younger age group (20–29) was
Table 1 Mean 7-min screen test score in different age groups, education category and sex of participants.
Orientation Memory Clock drawing Verbal fluency
Age N M SD M SD M SD M SD
7 min screen test
Age group
20–29 60 0.35 0.481 15.6 0.527 6.37 0.736 23.15 2.441
30–39 58 0.71 0.726 15.34 0.637 6.28 0.951 22.93 2.937
40–49 57 1.07 0.799 15.09 0.714 6.02 0.896 22.35 2.949
50–59 52 1.56 0.873 14.92 0.652 5.75 1.118 21.35 2.424
60–60 48 2.17 0.859 14.73 0.644 5.33 1.294 20.00 2.642
70–79 43 2.81 0.588 14.28 0.908 4.51 1.162 17.60 2.331
P80 19 3.74 0.452 12.63 0.895 3.47 0.513 13.63 1.342
Total 337 1.48 1.205 14.91 0.971 5.65 1.273 21.01 3.618
Educational group
Primary 129 2.02 1.104 14.52 0.985 5.17 1.347 19.47 3.300
Secondary 144 1.23 1.163 15.06 0.937 5.85 1.202 21.38 3.363
Tertiary 64 0.98 1.105 15.34 0.718 6.17 0.918 23.28 3.402
Total 337 1.48 1.205 14.91 0.971 5.65 1.273 21.01 3.618
Sex group
Male 174 1.40 1.142 15.10 0.802 5.78 1.245 21.48 3.523
Female 163 1.58 1.266 14.70 1.089 5.52 1.293 20.50 3.661
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± 0.90. A statistically significant difference was found between
younger and older age groups (p< 0.001). Mean square value
from one way ANOVA revealed a highly significant change
(p< 0.001) between the groups and within the groups
(26.442 and 0.48 respectively). The score of male and female
was compared and the values were 15.1 ± 0.802 and 14.7
± 1.089 respectively. A statistically significant difference was
observed between the scores in male and female (p< 0.001).
A statistically significant difference was observed between the
highly educated participants and the uneducated in the mem-
ory test score (p< 0.001). In primary educated group, the
value was 14.52 ± 0.99, in secondary, it was 15.06 ± 0.94,
but in tertiary educated group, it was 15.34 ± 0.71. Statisti-
cally the values were highly significant (p< 0.001).
The clock drawing test was administered in all the partici-
pants and correlated. The result showed a decreasing trend
as age advances. In the younger age group (20–29) the value
was 6.37 ± 0.74; however, the value in subjects above 80 years
was 3.47 ± 0.51. One way ANOVA revealed a statistically sig-
nificant difference (p< 0.001) between the groups and within
the groups with a mean square value of 35.38 and 1.007. The
score was found to be increased as the education level
advanced. The score of male was 5.78 ± 1.25 and for female
it was 5.52 ± 1.29. A statistically significant difference was
observed between the scores in male and female (p= 0.06).
A statistically significant difference was observed between the
highly educated participants and the uneducated in the clock
drawing test score (p< 0.001). In the primary educated group,
the value was 5.17 ± 1.35, in the secondary educated group, it
was 5.85 ± 1.20, but in the tertiary educated group it was 6.17
± 0.92. Statistically the values were highly significant
(p< 0.001).
Verbal fluency (Semantic category) test was administered in
all the participants and it was found a decreasing trend in the
score as age advances. Verbal fluency test in younger age group
was compared with all other groups. One way ANOVArevealed a statistically significant difference (p< 0.001)
between younger age and the older age groups with a mean
square value between the groups and within the groups with
a value of 363.19 and 6.72 respectively. It was found that as
the education level increased the verbal fluency score also
increased. A statistically significant difference was observed
between the subjects with higher education level and those with
lower education level. In subjects who completed tertiary level
of education, the score was found to be higher than the pri-
mary educated group. The scores in the tertiary educated
group and uneducated primary group were compared and
found to be statistically significant (p< 0.001), which shows
that there is cognitive impairment in uneducated and elderly
participants. The verbal fluency test in male and female was
also compared. The score in male and female was 21.48
± 3.52 and 20.5 ± 3.661 respectively. Statistically significant
difference was observed between the scores of males and
females (p< 0.001).
Based on the 7-min screen test, probability of dementia in
the different age groups was also calculated. The participants
with 75.81 ± 6.93 age (n= 43) showed high probability to
dementia (HI) than the lower age group ‘LO’ (44.33
± 16.56, n= 286). A statistically significant difference in
dementia probability was observed between the higher and
lower age groups (p< 0.001) (Table 2), of which eight subjects
were rechecked (RE). Among HI dementia probability with
Alzheimer’s characteristics, 39.5% was male and 60.5% was
female. However, we got an interesting finding that as the sta-
tus of education increased the chances of dementia with char-
acteristics of Alzheimer’s disease decreased (p< 0.001)
(Table 3).
Out of these selected participants, 37.5% belonged to HI
group, 37.5% belonged to LO group and remaining 25%
belonged to RE group based on the 7-min screen test. All
the participants were well matched for age and sex. A number
of cognitive assessment tests were used to evaluate cognitive
function in this population and a composite score was created
Table 2 Dementia probability in different age groups
(descriptive).
N Mean age SD 95% Confidence interval for
mean
Lower bound Upper bound
Dementia probability of Alzheimer’s characteristics
HI 43 75.81 6.929 73.68 77.95
LO 286 44.33 16.564 42.4 46.26
RE 8 67.75 5.12 63.47 72.03
Total 337 48.91 18.926 46.88 50.93
306 M.P. Basheer et al.to represent cognitive function/impairment. Descriptive statis-
tics for each biochemical test parameters are presented in
Table 4.
Serum Mg was estimated in all the participants. In the
dementia probability LO group, the mean serum Mg was
2.06 ± 0.25 and in the HI group it was 1.36 ± 0.14. One
way ANOVA was conducted between the groups and within
the groups which showed a highly significant change. Between
the groups the mean square value was 1.566 with a p value of
<0.001 and within the groups the value was 0.034 with a p
value of <0.0031 (Fig. 1).
Serum Ca was estimated in all the participants. In the
dementia probability LO group, the mean serum Ca was
10.55 ± 0.51 and in the HI group it was 8.97 ± 0.26. One
way ANOVA was conducted between the groups and within
the groups, which showed a highly significant change. Between
the groups, the mean square value was 8.19 with a p value of
<0.001 and within the groups the value was 0.17 with a p
value of <0.001 (Fig. 2).
Serum P was estimated in all the participants. In the
dementia probability LO group, the mean serum phosphorus
was 2.70 ± 0.19 and in the HI group it was 4.00 ± 0.54.
One way ANOVA was conducted between the groups and
within the groups which showed highly significant changes.
Between the groups, the mean square value was 5.16 with a
p value of <0.001 and within the groups the value was 0.16
with a p value of <0.001(Fig. 3).
4. Discussion
Macronutrients are chemical elements that are needed for the
proper growth, development and physiology of the organism.Table 3 Dementia probability in different education category and
Educational level
Primary Secondary Tertiary
Dementia characteristic of Alzheimer’s disease
HI 27 13 3
62.80% 30.20% 7.00%
LO 97 129 60
33.90% 45.10% 21.00%
RE 5 2 1
62.50% 25.00% 12.50%
Total 129 144 64
38.30% 42.70% 19.00%Macronutrients are routinely involved in metabolic processes
and oxidation–reduction reactions in the CNS and could have
a possible effect on cognitive function.
All the three macronutrients that we estimated (calcium,
magnesium and phosphorus) were found to be significantly
related to the composite cognitive score. Increasing plasma cal-
cium and magnesium level was associated with higher cogni-
tive score (p< 0.0001). Increasing phosphorus, in contrast,
was significantly associated with lower composite score. The
relationship between trace elements measured in dietary intake
or in drinking water and cognitive function in elderly persons
has been examined previously and calcium levels in drinking
water have a positive association with cognitive function.17–19
In this sample of our elderly participants, we found a signif-
icant association between increased plasma calcium and mag-
nesium levels and higher cognitive function scores. We also
identified plasma phosphorus level as a factor associated with
lower cognitive scores. The mechanisms between the associa-
tion of micro, macronutrients and brain functions are thought
to be through impact on neurotransmitting processes, oxy-
genation in the cerebral parenchyma, in the synthesis of neuro-
transmitters and in the formation of calcification in the brain.
Another study in women showed that Alzheimer’s patients had
lower serum calcium levels compared to non-demented
women.20 The mechanism for calcium’s impact on brain func-
tion is hypothesized to be that, increased calcium level
enhances brain dopamine synthesis through a calmodulin-
dependent system and increased dopamine levels regulate var-
ious brain functions.21
The association between plasma phosphorus level and cog-
nitive score, we report in this study, is consistent with previous
findings22, where the mechanism for phosphorus and its
impact on cognition is believed to be its interaction with calci-
fication in the basal ganglia, thalamus and cerebral white mat-
ter, which is associated with cognitive impairment. In another
study23 it was observed that a decreased serum phosphorus
reduced arterial stiffness and improved cognitive function
and renal disease. The mean phosphorus level in our ‘HI’ sam-
ple (4 mg/dL) was slightly higher than the mean plasma phos-
phorus level reported in ‘LO’ participants (2.7 mg/dL).
Magnesium plays a vital role in neurochemical transmission
and therefore its deficiency has been related to a number of dis-
orders of the central nervous system. The water-soluble vita-
mins (B group and C), together with the minerals, calcium,
magnesium and zinc are most relevant for cognitive perfor-
mance.24 Clinical evidence revealed that marginal deficienciessex (crosstab).
Sex
Total Male Female Total
43 17 26 43
100.00% 39.5% 60.5% 100%
286 153 133 286
100.00% 53.5% 46.5% 100.0%
8 4 4 8
100.00% 50.0% 50.0% 100%
337 174 163 337
100.00% 51.6% 48.4% 100.0%
Table 4 Mean serum magnesium, calcium and phosphorus values in different categories (mg/dL).
Magnesium Calcium Phosphorus
Mean SD SE Mean SD SE Mean SD SE
Dementia probability
HI 1.358 0.1443 0.042 8.967 0.264 0.0762 4 0.5377 0.1552
LO 2.058 0.2539 0.073 10.55 0.5143 0.1485 2.7 0.1859 0.0537
RE 1.888 0.0835 0.03 9.288 0.4324 0.1529 3.175 0.4062 0.1436
Total 1.753 0.3645 0.064 9.641 0.83 0.1467 3.306 0.6965 0.1231
Figure 1 Mean serum level of magnesium in different categories
of participants.
Figure 2 Mean serum level of calcium in different categories of
participants.
Figure 3 Mean serum level of phosphorus in different categories
of participants.
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the developed countries and that, such deficiencies may affect
cognitive performance, especially in vulnerable groups such as
the elderly and those individuals who are exposed to occupa-
tional pressures and a stressful lifestyle.25 Magnesium is also
crucial to many functions of cell metabolism. In patients with
Alzheimer’s disease, increased severity of cognitive impairment
is significantly associated with lower levels of serum magne-
sium26 and in hypertensive patients, reduced cognitive perfor-
mance has also been associated with lower magnesium level.27A review of the literature on magnesium and dementia
suggests that magnesium supplementation could have neuro-
protective effects in aging and specifically in dementia patients
and is already shown to facilitate learning and memory
performance.28
In an animal study it has been observed that an increase in
brain magnesium improves learning and memory in young and
old rats and suggests that increasing magnesium intake may be
a valid strategy to enhance cognitive abilities and supports
speculation that inadequate levels of magnesium impair cogni-
tive function, leading to faster deterioration of memory in
aging humans. Diet can have a significant impact on cognitive
capacity. Identification of dietary factors which have a positive
influence on synapses, the sites of communication between
neurons, might help to enhance learning and memory and pre-
vent their decline with age and disease. It is observed that mag-
nesium is essential for the proper functioning of many tissues
in the body, including the brain and demonstrated that magne-
sium promoted synaptic plasticity in cultured brain cells and
boost brain power.29 It is also found that increased brain mag-
nesium enhanced many different forms of learning and mem-
ory in both young and aged rats. A close examination of
cellular changes associated with memory revealed an increase
in the number of functional synapses, activation of key signal-
ing molecules and an enhancement of short- and long-term
synaptic processes that are crucial for learning and memory.
A recent study on animals30 showed that elevating brain mag-
nesium was effective at preventing/reversing learning and
memory deterioration in transgenic (Tg) mice.
Elevation of brain magnesium was effective at restoring
synapse density at the end stage of AD-like pathological
308 M.P. Basheer et al.progression in Tg mice, which might be responsible for the
restoration of cognitive functions.
5. Conclusion
The results of our study give us an expression that macronutri-
ents such as calcium, magnesium and phosphorus may be asso-
ciated with cognitive function in elderly population. Calcium
and magnesium are associated with cognitive improvement
in elderly, but in contrast, higher level of phosphorus facilitates
cognitive decline. But further studies on a large population are
required to come out with a definite conclusion. Our findings
suggest that elevating brain magnesium content via increasing
magnesium intake might be a useful new strategy to enhance
cognitive abilities. Moreover, half the population of industrial-
ized/developing countries have magnesium deficit, which
increases with aging. This may very well contribute to age-
dependent memory decline; increasing magnesium intake
might prevent or reduce such decline in memory. Our results
demonstrate the existence of a significant association between
magnesium imbalance and cognitive impairment.
Conflict of interest
None. All the study participants had given their informedwritten
consent and study was approved by Human ethical committee.
References
1. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM,
Bloxham CA, et al. Iron and aluminium in relation to brain
ferritin in normal individuals and Alzheimer’s disease and chronic
renal-dialysis patients. Biochem J 1992;287:509–14.
2. Deloncle R, Guillard O. Mechanism of Alzheimer’s disease:
arguments for a neurotransmitter–aluminium complex implica-
tion. Neurochem Res 1990;15:1239–45.
3. Dexter DT, Carayon A, Agid FI, Agid I, Wells FR, Daniel SE,
et al. Alterations in the levels of iron, ferritin and other trace
metals in Parkinson’s disease and other neurodegenerative disease
affecting the basal ganglia. Brain 1991;114:1953–75.
4. Durlach J, Bac P. Mechanisms of action on the nervous system in
magnesium deficiency and dementia. In: Jasui M, Strong MJ, Ota
MA, Verity MA, editors.Mineral and metal neurotoxicology. Boca
Raton: CRC; 1997. p. 201–10.
5. Mitani K. Relationship between neurological diseases due to
aluminium load, especially amyotrophic lateral sclerosis and
magnesium status. Magn Res 1992;5:203–13.
6. Altura BM, Altura BT. Magnesium ions and contraction of
vascular smooth muscles: relationship to some vascular diseases.
Fed Proced 1981;40:2672–9.
7. Altura BT, Altura BM. Withdrawal of magnesium causes
vasospasm while elevated magnesium produces relaxation of tone
in cerebral arteries. Neurosci Lett 1980;20:323–7.
8. Iseri LT, French JH. Magnesium: nature’s physiologic calcium
antagonist. Am Heart J 1984;108:188–93.
9. Mayer ML, Westbrook GL, Guthrie PB. Voltage – dependent
block by Mg2+ of NMDA responses in spinal cord neurons.
Nature 1984;309:261–3.
10. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A.
Magnesium gates glutamate-activated channels in mouse central
neurons. Nature 1984;307:462–5.11. Altura BT, Altura BM. A method for distinguishing ionized,
complexed and protein-bound Mg in normal and diseased
subjects. Scand J Clin Lab Invest Suppl 1994;217:83–7.
12. Slutsky I, Sadeghpour S, Li B, Liu G. Enhancement of synaptic
plasticity through chronically reduced Ca2+ flux during uncorre-
lated activity. Neuron 2004;44:835–49.
13. Glick JL. Proposed mechanisms for alteration of albumin struc-
ture and function in Alzheimer’s disease. J Theor Biol 1991;148:
283–6.
14. Ramesh J, Madhav TR, Vatsala S, Ramakrishna T, Easwaran O,
Guillard KRK, et al. Interaction of Ab peptide (1–40) with amino
acid-aluminium complexes: relevance to Alzheimer’s disease.
Alzheimer’s Rep 1999;2(1):31–5.
15. De jager CA, Thambisetty Madhav, Praveen KV, Sheeba PD,
Ajini KN, Sajeev A, et al. Utility of the Malayalam translation of
the 7-min screen for Alzheimers’s disease risk in an Indian
community. Neurol India 2008;56(2):161–6.
16. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux
RD, et al. A 7 min screening battery highly sensitive to
Alzheimer’s disease. Arch Neurol 1998;55:354.
17. Jacqmin H, Commenges D, Letenneur L, Barberger-Gateau P,
Dartigues JF. Components of drinking water and risk of cognitive
impairment in the elderly. Am J Epidemiol 1994;139:48–57.
18. Jacqmin-Gadda H, Commenges D, Letenneur L, Dartigues JF.
Silica and aluminum in drinking water and cognitive impairment
in the elderly. Epidemiology 1996;7:281–5.
19. Emsley CL, Gao S, Li Y, Liang C, Ji R, Hall KS, et al. Trace
element levels in drinking water and cognitive function among
elderly Chinese. Am J Epidemiol 2000;151:913–20.
20. Ogihara T, Miya K, Morimoto S. Possible participation of
calcium-regulating factors in senile dementia in elderly female
subjects. Gerontology 1990;36(Suppl 1):25–30.
21. Sutoo D, Akiyama K. Regulation of brain functions by exercise.
Neurobiol Dis 2003;13:1–14.
22. Titlic M, Tonkic A, Jukic I, Filipovic-Grcic P, Kolic K. Cognitive
impairment and epilepsy seizure caused by hypoparathyroidism,
case report. Bratisl Lek Listy 2008;109(2):79–81.
23. Alan SK. More intensive hemodialysis. J Am Soc Nephrol
2009;4:121–4.
24. Ramakrishna T. Vitamins and brain development. Phys Res
1999;48:175–87.
25. Huskisson E, Maggini S, Ruf M. The influence of micronutrients
on cognitive function and performance. J Int Med Res 2007;35
(1):1–19.
26. Cilliler AE, Ozturk S, Ozbakir S. Serum magnesium level and
clinical deterioration in Alzheimer’s disease. Gerontology 2007;53
(6):419–22.
27. Corsonello A, Pedone C, Pahor M, Malara A, Carosella L,
Mazzei B, et al. GruppoItaliano di Farmacovigilanzanell’Anziano
(GIFA). Serum magnesium levels and cognitive impairment
in hospitalized hypertensive patients. Magn Res 2001;14(4):
273–82.
28. Ozturk S, Cillier AE. Magnesium supplementation in the
treatment of dementia patients. Med Hypotheses 2006;67(5):
1223–5.
29. Guosong Liu, Inna Slutsky, Nashat Abumaria, Long-Jun Wu,
Chao Huang, Ling Zhang, et al. Enhancement of learning and
memory by elevating brain magnesium. Neuron 2010;65(2):165–77.
http://dx.doi.org/10.1016/j.neuron.2009.12.02, January 28.
30. Wei Li, Jia Yu, Yong Liu, Xiaojie Huang, Nashat Abumaria, Ying
Zhu, et al. Elevation of brain magnesium prevents and reverses
cognitive deficits and synaptic loss in Alzheimer’s disease mouse
model. J Neurosci 2013;33(19):8423–41, May 8.
